November 11, 2025 · Form 4 insider transaction
Oelschlager Kristen M sold 18,932 shares of Castle Biosciences, Inc. at $35.10 per share, a transaction worth $664.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 6, 2025; This transaction was executed in multiple trades at prices ranging from $35.00 to $35.37, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; On November 11, 2025, the Reporting Person transferred 3,686 shares from the Fritz Shorter Trust to their direct holdings.